238
Participants
Start Date
July 31, 2023
Primary Completion Date
June 19, 2025
Study Completion Date
June 19, 2025
Orforglipron
Administered orally
Placebo
Administered orally
Nishiyamadou Keiwa Hospital, Naka
Tsuchiura Beryl Clinic, Tsuchiura
Ohishi Internal Medicine Clinic, Tsuchiura
Shonan Takai Clinic, Kamakura
Takai Internal Medicine Clinic, Kamakura-shi
Medical Corporation Yuga Higashirinkan Kaneshiro Diabetes Clinic, Sagamihara
Shiraiwa Medical Clinic, Kashihara
Medical Corporation Heishinkai OCROM Clinic, Suita-shi
Sugiura Clinic, Kawaguchi
Yotsuya Medical Cube, Chiyoda City
Nihonbashi Sakura Clinic, Chuo-ku
Tokyo-Eki Center-building Clinic, Chuo-ku
Fukuwa Clinic, Chuo-ku
Heishinkai Medical Group ToCROM Clinic, Shinjuku-ku
Hiroshima Station Clinic, Hiroshima
Osaka Nishiumeda Clinic, Osaka
Eli Lilly and Company
INDUSTRY